Form 4: Zimmer Biomet Exec Reports Stock Transactions

Chad F. Phipps, a Senior VP at Zimmer Biomet, reported the vesting of restricted stock units and a new RSU grant, alongside shares withheld for tax obligations.

Summary

• Chad F. Phipps, Senior Vice President, Chief Legal, Corporate Affairs Officer and Secretary of Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock and restricted stock units (RSUs).
• On February 20, 2026, 2,246 shares of common stock were acquired upon the vesting of RSUs.
• Concurrently, 942 shares of common stock were disposed of at a price of $98.62 per share to satisfy tax withholding obligations related to the RSU vesting.
• Phipps' direct beneficial ownership of common stock after these transactions is 62,137 shares. This total includes 795 shares acquired through the Employee Stock Purchase Plan and dividend reinvestment between May 1, 2025, and February 20, 2026.
• Additionally, Phipps was granted 9,818 new Restricted Stock Units (RSUs) on February 20, 2026. These new RSUs will vest annually over three years, with the first one-third vesting on February 20, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing routine executive compensation activities and compliance with SEC disclosure requirements rather than a significant change in company fundamentals or outlook.

Positives

• Acquisition of 2,246 shares of common stock through the vesting of Restricted Stock Units (RSUs), increasing direct ownership.
• Grant of 9,818 new Restricted Stock Units (RSUs), representing future equity compensation and alignment with shareholder interests.
• Accumulation of 795 shares through the Employee Stock Purchase Plan and dividend reinvestment, indicating ongoing investment in the company.

Negatives

• Disposition of 942 shares of common stock at $98.62 per share to cover tax withholding obligations, a standard practice upon RSU vesting.

Future Outlook

The newly granted 9,818 Restricted Stock Units (RSUs) are scheduled to vest annually over three years, with the first one-third vesting on February 20, 2027.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive stock ownership and compensation. These transactions, particularly those related to RSU vesting and grants, are common mechanisms for executive compensation and alignment with shareholder interests in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies, including those in the medical device sector.
• The reported RSU vesting and new grant for a Senior Vice President at Zimmer Biomet Holdings, Inc. are consistent with typical executive compensation structures seen at comparable medical technology companies such as Stryker Corporation or Medtronic plc, where equity-based incentives are a significant component of total compensation.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and stock ownership, indicating management's continued equity stake in the company.
• Employees: Reflects standard executive compensation practices, which may influence broader compensation strategies within the company.

Next Steps

• The newly granted 9,818 Restricted Stock Units (RSUs) will vest annually over three years, commencing February 20, 2027.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (RSU vesting and grant) and tax obligations. It does not provide new information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the fundamental investment thesis remains unchanged by this disclosure.

Keywords

Zimmer Biomet Holdings, ZBH, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership